1.Morphological and Microstructural Changes of the Hippocampus in Early MCI: A Study Utilizing the Alzheimer's Disease Neuroimaging Initiative Database.
Peter LEE ; Hojin RYOO ; Jinah PARK ; Yong JEONG
Journal of Clinical Neurology 2017;13(2):144-154
BACKGROUND AND PURPOSE: With the aim of facilitating the early detection of Alzheimer's disease, the Alzheimer's Disease Neuroimaging Initiative proposed two stages based on the memory performance: early mild cognitive impairment (EMCI) and late mild cognitive impairment (LMCI). The current study was designed to investigate structural differences in terms of surface atrophy and microstructural changes of the hippocampus in EMCI and LMCI. METHODS: Hippocampal shape modeling based on progressive template surface deformation was performed on T1-weighted MRI images obtained from 20 cognitive normal (CN) subjects, 17 EMCI patients, and 20 LMCI patients. A template surface in CN was used as a region of interest for diffusion-tensor imaging (DTI) voxel-based morphometry (VBM) analysis. Cluster-wise group comparison was performed based on DTI indices within the hippocampus. Linear regression was performed to identify correlations between DTI metrics and clinical scores. RESULTS: The hippocampal surface analysis showed significant atrophies in bilateral CA1 regions and the right ventral subiculum in EMCI, in contrast to widespread atrophy in LMCI. DTI VBM analysis showed increased diffusivity in the CA2–CA4 regions in EMCI and additionally in the subiculum region in LMCI. Hippocampal diffusivity was significantly correlated with scores both for the Mini Mental State Examination and on the Modified Alzheimer Disease Assessment Scale cognitive subscale. However, the hippocampal diffusivity did not vary significantly with the fractional anisotropy. CONCLUSIONS: EMCI showed hippocampal surface changes mainly in the CA1 region and ventral subiculum. Diffusivity increased mainly in the CA2–CA4 regions in EMCI, while it decreased throughout the hippocampus in LMCI. Although axial diffusivity showed prominent changes in the right hippocampus in EMCI, future studies need to confirm the presence of this laterality difference. In addition, diffusivity is strongly correlated with the cognitive performance, indicating the possibility of using diffusivity as a biomarker for disease progression.
Alzheimer Disease*
;
Anisotropy
;
Atrophy
;
Biomarkers
;
Disease Progression
;
Hippocampus*
;
Humans
;
Linear Models
;
Magnetic Resonance Imaging
;
Memory
;
Mild Cognitive Impairment
;
Neuroimaging*
2.A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease.
YoungSoon YANG ; Hojin CHOI ; Chan Nyoung LEE ; Yong Bum KIM ; Yong Tae KWAK
Dementia and Neurocognitive Disorders 2018;17(1):1-10
BACKGROUND AND PURPOSE: Acetyl-L-carnitine (ALC) is a widely used drug for various neurodegenerative diseases including dementia. The aim of the present study was to elucidate the efficacy of ALC in dementia patients with cerebrovascular disease (vascular cognitive impairment; VCI). METHODS: Fifty-six patients were randomized to treatment with 500 mg ter in die ALC, or placebo in this 28-week, double-blind, placebo-controlled trial. The primary outcome measure was the Korean version of Montreal Cognitive Assessment (MoCA-K). RESULTS: Following treatment with ALC, the cognitive function measured by the MoCA-K was significantly improved in the ALC-treated groups. However, other secondary outcomes were not statistically significant between ALC- and placebo-treated groups. In MoCA-K analysis, attention and language sub-items significantly favored the ALC-treated group. CONCLUSIONS: Compared with placebo, treatment with ALC 1,500 mg/day produced significant changes in MoCA-K in dementia patients with VCI. ALC was well tolerated in this population. Despite the study limitations, the findings suggested the potential benefits associated with the use of ALC in dementia patients with VCI.
Acetylcarnitine*
;
Cerebrovascular Disorders*
;
Cognition
;
Cognition Disorders
;
Dementia*
;
Humans
;
Neurodegenerative Diseases
;
Outcome Assessment (Health Care)
3.Candesartan Restores the Amyloid Beta-Inhibited Proliferation of Neural Stem Cells by Activating the Phosphatidylinositol 3-Kinase Pathway.
Hojin CHOI ; Na Young CHOI ; Kyu Yong LEE ; Young Joo LEE ; Seong Ho KOH
Dementia and Neurocognitive Disorders 2017;16(3):64-71
BACKGROUND AND PURPOSE: Neurogenesis in the adult brain is important for memory and learning, and the alterations in neural stem cells (NSCs) may be an important aspect of Alzheimer's disease (AD) pathogenesis. The phosphatidylinositol 3-kinase (PI3K) pathway has been suggested to have an important role in neuronal cell survival and is highly involved in adult neurogenesis. Candesartan is an angiotensin II receptor antagonist used for the treatment of hypertension and several studies have reported that it also has some neuroprotective effects. We investigated whether candesartan could restore the amyloid-β(25–35) (Aβ₂₅₋₃₅) oligomer-inhibited proliferation of NSCs by focusing on the PI3K pathway. METHODS: To evaluate the effects of candesartan on the Aβ₂₅₋₃₅ oligomer-inhibited proliferation of NSCs, the NSCs were treated with several concentrations of candesartan and/or Aβ₂₅₋₃₅ oligomers, and MTT assay and trypan blue staining were performed. To evaluate the effect of candesartan on the Aβ-inhibited proliferation of NSCs, we performed a bromodeoxyuridine (BrdU) labeling assay. The levels of p85α PI3K, phosphorylated Akt (pAkt) (Ser473), phosphorylated glycogen sinthase kinase-3β (pGSK-3β) (Ser9), and heat shock transcription factor-1 (HSTF-1) were analyzed by Western blotting. RESULTS: The BrdU assays demonstrated that NSC proliferation decreased with Aβ25-35 oligomer treatment; however, a combined treatment with candesartan restored it. Western blotting displayed that candesartan treatment increased the expression levels of p85α PI3K, pAkt (Ser473), pGSK-3β (Ser9), and HSTF. The NSCs were pretreated with a PI3K inhibitor, LY294002; the effects of candesartan on the proliferation of NSCs inhibited by Aβ₂₅₋₃₅ oligomers were almost completely blocked. CONCLUSIONS: Together, these results suggest that candesartan restores the Aβ₂₅₋₃₅ oligomer-inhibited proliferation of NSCs by activating the PI3K pathway.
Adult
;
Alzheimer Disease
;
Amyloid*
;
Blotting, Western
;
Brain
;
Bromodeoxyuridine
;
Cell Survival
;
Glycogen
;
Hot Temperature
;
Humans
;
Hypertension
;
Learning
;
Memory
;
Neural Stem Cells*
;
Neurogenesis
;
Neurons
;
Neuroprotective Agents
;
Phosphatidylinositol 3-Kinase*
;
Phosphatidylinositols*
;
Receptors, Angiotensin
;
Shock
;
Trypan Blue
4.Fatal Intracranial Hemorrhage in a Patient with Disseminated Intravascular Coagulation associated with Sepsis.
Hyun Jin BAEK ; Doo Hyuk LEE ; Kyu Hyung HAN ; Young Min KIM ; Hyunbeom KIM ; Byeongwook CHO ; Inkuk LEE ; Kanghyun CHOI ; Hojin YONG ; Goohyeon HONG
Korean Journal of Critical Care Medicine 2016;31(2):134-139
In critically ill patients, disseminated intravascular coagulation (DIC) is a common and fatal hematological disorder. DIC is a physiological response to a variety of underlying stimuli that provoke generalized activation of the hemostatic mechanism and is common in septic patients and those with hematological or non-hematological malignant neoplasms. Bleeding is a common clinical feature, and diffuse or multiple-site mucocutaneous bleeding, such as petechia, ecchymosis and hemorrhage from gastrointestinal tract, is often seen. A 58-year-old male was recently diagnosed with intracranial hemorrhage (ICH) caused by DIC associated with sepsis. Mortality of ICH caused by DIC is very high because the underlying condition cannot be quickly treated. Awareness of the possibility of DIC developing in a critically ill patient and the need for immediate initiation of plasma or platelet replacement therapy are important. To the best of our knowledge, this is the first reported case of intracranial hemorrhage in a Korean patient with DIC associated with sepsis.
Blood Platelets
;
Critical Illness
;
Dacarbazine
;
Disseminated Intravascular Coagulation*
;
Ecchymosis
;
Gastrointestinal Tract
;
Hemorrhage
;
Humans
;
Intracranial Hemorrhages*
;
Male
;
Middle Aged
;
Mortality
;
Plasma
;
Sepsis*
5.A Case of Down Syndrome with Atlanto-axial Dislocation.
Won Yong LEE ; Kwang Kuk KIM ; Jong Sung KIM ; Kwang Woo LEE ; Jae Kyu RHO ; Sang Bok LEE ; Hojin MYUNG
Journal of the Korean Neurological Association 1989;7(1):131-139
Atlanto-axial instability in children with Down syndrome(trisomy 21) has become a wel! Known entity and it has been reported frequently since it was first reported over 25 years ago. However, symtomatic atlanto-axial dislocation associated with cord compression is relatively rare and it had seldom been reported. We recently experienced a 14-year-old mongoloid female with progressive quadriparesis, who have no prior cervical inflammation and we detected atlanto-axial dislocation with ossculum terminale and cord compression through radiological evaluations. We report a case of symptomatic atlanto-axial dislocation in Down syndrome with review.
Adolescent
;
Child
;
Dislocations*
;
Down Syndrome*
;
Female
;
Humans
;
Inflammation
;
Quadriplegia
6.A Case of Progressive Multifocal Leukoencephalopathy in Acquired Immune Deficiency Syndrome Initially Presented with Early Onset Dementia.
Pyeong Kang PARK ; Jung Geun OH ; Seong Ho KOH ; Kyu Yong LEE ; Young Joo LEE ; Hojin CHOI
Dementia and Neurocognitive Disorders 2014;13(1):20-23
Progressive multifocal leukoencephalopathy (PML) is a very rare and often fatal demyelinating disease of central nervous system (CNS), which mostly occurs in patients with immunosuppression such as acquired immunodeficiency syndrome (AIDS) patients, transplant patients and patients receiving chemotherapy. PML usually manifests with acute or subacute neurologic deficit. and its late diagnosis may lead death or significant permanent disability. We report a 33-year old man diagnosed with PML in AIDS, who initially presented with gradual onset of dementia. Most symptoms of PML were progressed rapidly for several months, and characterized by focal neurological symptoms. On the other hand, we were experienced in patients without focal neurological symptoms and ongoing overall cognitive decline slowly. Patients with immunosuppression can be presented in a variety of neurological symptoms, detailed examinations for cognitive functions were needed in early stage of the disease.
Acquired Immunodeficiency Syndrome*
;
Adult
;
Central Nervous System
;
Delayed Diagnosis
;
Dementia*
;
Demyelinating Diseases
;
Drug Therapy
;
Hand
;
Humans
;
Immunosuppression
;
Leukoencephalopathy, Progressive Multifocal*
;
Neurologic Manifestations
7.Two Cases with Bilateral Adie's Pupils.
Byoung Joon KIM ; Sang Kun LEE ; Won Yong LEE ; Jae Kyu ROH ; Sang Bok LEE ; Hojin MYUNG ; Seoul Heui HAN
Journal of the Korean Neurological Association 1990;8(1):92-97
Adie's tonic pupil usually consists of mydriasis, defect in accommodation. Poor or absent light reflex, and tonic near reflex, It is usually unilateral, but rarelY observed bilaterally. The pupillary abnormalities often accompany areflexia, which is called Adie syndrome collechvely, Other autonomic dysfunction especially hypohidrosis. Are rarely reported in association with Adie syndrome. We recently experienced 2 cases of bilateral Adie's pupils in 2 women, one of whom had hypohidrosis, and the other had areflexia. So we report 2 cases with bilateral Adie's pupils with a review of literature.
Adie Syndrome
;
Female
;
Humans
;
Hypohidrosis
;
Mydriasis
;
Reflex
;
Tonic Pupil*
8.A Case of Pseudotumor Cerebri Associated with Primary Antiphospholipid Syndrome.
Hojin CHOI ; Gwangsu HAN ; Young Seo KIM ; Won Ki PAEK ; Kyu Yong LEE ; Young Joo LEE
Journal of the Korean Neurological Association 2005;23(4):554-556
Antiphospholipid syndrome may be associated with various neurologic conditions. Pseudotumor cerebri is a rare complication of the disease and is often attributed to venous thrombosis. We report a 18-year-old woman with pseudotumor cerebri due to primary antiphospholipid syndrome. She has normal findings on MR venography. Antiphospholipid syndrome should be considered in the differential diagnosis of pseudotumor cerebri, even in the patients without evidence of venous thrombosis on MR angiography.
Adolescent
;
Angiography
;
Antiphospholipid Syndrome*
;
Diagnosis, Differential
;
Female
;
Humans
;
Phlebography
;
Pseudotumor Cerebri*
;
Venous Thrombosis
9.Cerebral Paragonimiasis Presenting as Recurrent Hemorrhagic Stroke without Pulmonary Symptoms.
Sung Hwan LIM ; Hojin CHOI ; Kyu Yong LEE ; Young Joo LEE ; Seong Ho KOH
Journal of the Korean Neurological Association 2011;29(4):371-373
No abstract available.
Paragonimiasis
;
Paragonimus westermani
;
Stroke
10.MR demonstration of cryptic vascular malformation producing a palatal myoclonus: a case report.
Seol Heui HAN ; Won Yong LEE ; Jong Sung KIM ; Jae Kyu ROH ; Sang Bok LEE ; Hojin MYUNG
Journal of Korean Medical Science 1989;4(3):139-141
A 47-year-old man had suffered oscillopsia associated with palatal myoclonus for 10 years. High-field magnetic resonance imaging (MRI) revealed a cryptic vascular malformation within the "Guillain-Mollaret triangle" which was thought to be the responsible lesion.
Brain Stem/*abnormalities/pathology
;
Humans
;
*Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Myoclonus/*etiology